HSCA Applauds House Energy and Commerce Committee and Senate HELP Committee for Advancing Bipartisan Biosimilars Legislation that Will Help Increase Access to Safe Medications
Washington, D.C. (July 29, 2026) – The Healthcare Supply Chain Association (HSCA) and its traditional healthcare group purchasing organization (GPO) members commend the U.S. House Committee on Energy and Commerce for unanimously advancing two bipartisan bills that would expand patient access to lower-cost biosimilars: the Expedited Access to Biosimilars Act (H.R. 9661), led by Reps. Nick Langworthy (R-NY) and Kim Schrier (D-WA), and the Biosimilar Red Tape Elimination Act (H.R. 5526), led by Reps. August Pfluger (R-TX) and Greg Landsman (D-OH). This comes after the Senate Health, Education, Labor, and Pensions (HELP) Committee’s recent advancement of two companion bills, the Expedited Access to Biosimilars Act (S.1414), led by Sen. Rand Paul (R-KY), and the Biosimilars Red Tape Elimination Act (S.1954), led by Sens. Mike Lee (R-UT) and Ben Ray Lujan (D-NM).
“Biosimilars are one of the most effective tools for expanding generic competition in the prescription drug marketplace. Biosimilars have the potential to increase patient access to life-saving medications and reduce costs for the entire healthcare system,” said HSCA President and CEO Angie Boliver. “HSCA has long advocated for policies that ensure a pathway to market for biosimilars that prioritize patient safety while encouraging development and uptake. Eliminating outdated, duplicative testing requirements will help patients get faster access to safe, affordable treatments.”
Click here to view the full statement.
Lear MoreHSCA Statement on House Energy and Commerce Health Subcommittee Hearing on “Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain”
Washington, DC (June 12, 2025) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released the following statement from President and CEO Angie Boliver regarding the House Energy and Commerce Committee’s recent Health Subcommittee hearing on Made in America: Strengthening Domestic Manufacturing and Our Health Care Supply Chain:
“The Healthcare Supply Chain Association (HSCA), which represents the leading traditional healthcare group purchasing organizations (GPOs), applauds the House Energy and Commerce Committee leadership for their work to enhance domestic manufacturing and resilience in the medical supply chain. As the sourcing and contracting partners to American hospitals and healthcare providers, traditional healthcare GPOs are committed to ensuring that hospitals and the patients they serve have continuous, reliable, and affordable access to medical products. We hope to continue working with bipartisan policymakers to bolster domestic manufacturing.
HSCA supports efforts to increase domestic capacity in the supply chain, and we are proud that our members are able to offer customers the opportunity to source necessary products domestically. GPOs work alongside manufacturers and healthcare providers to increase competition and promote domestic manufacturing, which is vital to ensuring patient access to essential medicines and products. During the COVID-19 pandemic, for example, a number of HSCA member GPOs launched programs to invest in domestic and geographically diverse manufacturers, helping expand production capacity and increase hospital access to critical supplies, including pharmaceuticals. GPOs also help bring new products to market with domestic manufacturers through long-term contracting – a key component designed to support manufacturer investment and sustainability.”
Click here to view the full statement.
Lear MoreHSCA Statement on Recent Executive Order to Promote Domestic Production of Critical Medicines
Washington, DC (May 20, 2025) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today released the following statement from President and CEO Angie Boliver regarding the recent Executive Order on Regulatory Relief to Promote Domestic Production of Critical Medicines:
“HSCA and its traditional healthcare group purchasing organization (GPO) members applaud the Trump Administration’s recent Executive Order on Regulatory Relief to Promote Domestic Production of Critical Medicines. HSCA has long advocated for policymakers to encourage investments in manufacturing capacity and quality, which are of critical importance for hospitals and the patients they serve. We support the Administration’s efforts to align foreign manufacturing facility inspections with those conducted domestically, including by increasing the fees for and number of inspections. Moreover, HSCA supports the order’s provisions focused on streamlining the permitting and construction of domestic manufacturing facilities. Expediting the building process for pharmaceutical manufacturing sites will help suppliers scale up domestic production quickly. We hope to continue working with the Administration on its domestic production objectives moving forward.”
Click here to view the full statement.
Lear MoreHSCA NAMES ANGIE BOLIVER AS PRESIDENT AND CEO
Washington, D.C. (June 10, 2024) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced that it has named GPO industry expert and public affairs veteran Angie Boliver as President and Chief Executive Officer (CEO). The announcement follows the retirement of former President and CEO Todd Ebert, who led HSCA for seven years.
Click here to read the full press release.
Lear MoreHSCA ANNOUNCES 2024 BOARD OF DIRECTORS AND NAMES CAPSTONE HEALTH ALLIANCE PRESIDENT AND CEO TIM BUGG CHAIR
Washington, DC (January 09, 2024) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced that Capstone Health Alliance President and CEO Tim Bugg will serve as Chair of HSCA’s Board of Directors, replacing TPC President and CEO Roger Nolan. HSCA also announced that Shoshana Krilow, Senior Vice President of Vizient; Rob Arreola, Chief Legal Officer of HealthTrust; Mark Phalen, Senior Vice President and Chief Financial Officer of TPC; and Dan Kistner, Group Senior Vice President of Provista, have joined the board as new members.
Click here to read the full response.
Lear More
HSCA NAMES CHILDREN’S HOSPITAL ASSOCIATION VICE PRESIDENT OF PHARMACY TERRI LYLE WILSON TO BOARD OF DIRECTORS
Washington, DC (September 20, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced that Children’s Hospital Association Vice President of Pharmacy Terri Lyle Wilson will serve on HSCA’s Board of Directors. The appointment comes after the departure of Children’s Hospital Association Vice President Jennifer Gedney, who served as Board Chair. TPC President and CEO Roger Nolan will replace Gedney as Immediate Chair.
Click here to read the full release.
Lear MoreHSCA ANNOUNCES INAUGURAL HEALTHCARE SUPPLY CHAIN LEADERSHIP SUMMIT
Washington, DC (May 9, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced the Supply Chain Leadership Summit, an event designed to foster greater collaboration between supply chain stakeholders. The three-day event, which takes place from October 3-5, 2023, will bring together leaders from across the healthcare supply chain to network, discuss best practices and current challenges, and evaluate strategies to build a more resilient supply chain.
Click here to read the full release.
Lear MoreHEALTHCARE SUPPLY CHAIN ASSOCIATION GROWS MEMBERSHIP, ADDS CAPSTONE HEALTH ALLIANCE AS A MEMBER
Washington, DC (May 4, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today welcomed Capstone Health Alliance as a member of the association. Capstone has been a driving force in healthcare since 2000, providing purchasing advantages for organizations of all types and sizes.
Click here to read the full release.
Lear MoreHEALTHCARE SUPPLY CHAIN ASSOCIATION ANNOUNCES HSCA CONNECT AFFILIATE PROGRAM TO IMPROVE SUPPLY CHAIN PROCESSES ACROSS THE HEALTHCARE CONTINUUM
Washington, DC (March 21, 2023) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced HSCA Connect, its new affiliate program, intended for stakeholders from different areas of the healthcare continuum. The program is open to manufacturers (including pharma, medtech, med supplies, laboratories), distributors, and service providers (legal, consultants, finance, analysts). Applications are now open, and interested organizations are encouraged to apply by June 1, 2023, for first consideration.
Click here to read the full release.
Lear MoreHEALTHCARE SUPPLY CHAIN ASSOCIATION JOINS END DRUG SHORTAGE ALLIANCE TO SAFEGUARD ACCESS TO ESSENTIAL MEDICATIONS
Washington, DC (October 12, 2022) – The Healthcare Supply Chain Association (HSCA), which represents the nation’s leading healthcare group purchasing organizations (GPOs), today announced it has joined a new coalition of diverse stakeholders to address drug shortages in the United States. The End Drug Shortages Alliance provides a forum for key stakeholders to take strategic aim at one of healthcare’s more pressing and enduring issues, drug shortages that disrupt patient care.
“Healthcare GPOs are critical partners helping hospitals and the healthcare system avert and mitigate the impact of drug shortages and have helped reduce the number of shortages by half over the last decade. The Healthcare Supply Chain Association is proud to join the End Drug Shortage Alliance alongside many of our member GPOs and looks forward to working with the coalition to identify durable solutions to drug shortages and protect patient access to care,” said HSCA President and CEO Todd Ebert.
The End Drug Shortages Alliance was launched in late 2021 to bring together industry stakeholders, including providers, group purchasing organizations, manufacturers, distributors, and other industry thought leaders and champions. Efforts will focus on improving access to medications through greater transparency across market participants, leading to improved quality manufacturing of medications and production of additional supply. Learn more at EndDrugShortages.com.
Click here to read the full release.
Lear More